gip and glp 1 receptors GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read The dual glucose-dependent insulinotropic polypeptide

Nutritional Support and Hydration During Tirzepatide Therapy GLP-1 medications like tirzepatide can reduce appetite so significantly that some patients unintentionally under-eat or become dehydratedboth of which increase diverticulitis risk

Abbreviations ALP: alkaline phosphatase ALT: alanine aminotransferase AST: aspartate aminotransferase CKD: chronic kidney disease GGT: gamma glutamyl transpeptidase HGF: hepatocyte growth factor HPP: hypophosphatasia NSHA: nonspherocytic hemolytic anemia PLP: pyridoxal 5-phosphate TNSALP: tissue-nonspecific alkaline phosphatase Declarations Acknowledgement The support of the Herman Lopata Chair in Hepatitis Research is gratefully acknowledged

Valproate-induced hyperammonemic encephalopathy

& Zhu, Y

HUBERMAN: Or by taking a peptide that increases the amount of growth hormone that we release, we are increasing our tumor growth risk and our cancer risk

Rethinam 2019)